Related Experiment Video
Updated: Feb 8, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation
Anne Bettina Beeskow1, Manuel Florian Struck2, Aboelyazid Elkilany1
1Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany.
Radiologist-guided analgosedation using midazolam and S-ketamine is a safe and effective alternative to general anesthesia for percutaneous thermal tumor ablation. This approach increases procedural capacity and reduces patient wait times for liver, kidney, and bone tumor treatments.
Area of Science:
- Oncology
- Radiology
- Anesthesiology
Background:
- Rising case numbers and limited anesthesia resources restrict capacity for percutaneous thermal tumor ablation.
- Radiologist-guided analgosedation presents a potential alternative to general anesthesia for selected ablation procedures.
- Limited scientific research exists on the feasibility of percutaneous thermal ablation under analgosedation.
Purpose of the Study:
- To evaluate the safety, technical success, and impact on procedural throughput of microwave (MWA) and radiofrequency ablation (RFA) under analgosedation.
- To assess the use of midazolam and S-ketamine for analgosedation in hepatic, renal, and osseous tumor ablations.
- To compare procedural volume and efficiency with general anesthesia.
Main Methods:
- Retrospective single-center study of 140 percutaneous tumor ablations in 115 patients.
- Procedures performed under radiologist-guided analgosedation with midazolam and S-ketamine (January 2022 - July 2024).
- Primary endpoint: sedation-related complications. Secondary endpoints: technical success, ablation complications, procedural volume changes.
Main Results:
- High technical success rate (98.3% completed as intended) with no major complications.
- One minor complication (CIRSE grade 1 subcapsular hepatic hematoma) and transient post-interventional vomiting in 3.5% of patients.
- Significant increase in procedural volume (2.1 to 6.3 ablations/month) and reduced mean in-room time (42 ± 34 min vs. 98 ± 42 min) compared to general anesthesia.
Conclusions:
- Radiologist-guided analgosedation with midazolam and S-ketamine is a feasible and safe approach for percutaneous thermal ablation of liver, kidney, and bone tumors.
- This method achieves high technical success without increasing complication rates and can significantly expand procedural capacity.
- Adequate training, structured workflows, and emergency preparedness are crucial for safe implementation.
Related Concept Videos
Lung Capacity
Respiratory Capacities
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
Respiratory Volumes and Capacities I
Heat Capacity: Problem-Solving
Determine the type of gas: The heat capacity of a gas depends on its molecular structure and the degree of freedom of its molecules. Different types of...
Buffers: Buffer Capacity
In the graph, pH is plotted as a function of the number of moles of base (Cb) added to a weak...
Respiratory Volumes and Capacities

